ITMCTR2026001738进行中(未招募)Unknown
Study on Formulation and Clinical Verification of Standardized Protocol for Transcutaneous Electrical Acupoint Stimulation in Promoting Postoperative Gastrointestinal Function Recovery After Peritoneal Cancer Surgery
Beijing Shijitan Hospital, Capital Medical University0 个研究点开始时间: 2026年7月31日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 75(—)
- 性别
- All
入选标准
- •(1) Patients with primary peritoneal carcinoma or peritoneal metastasis confirmed by imaging combined with pathological or cytological examination, who are planned to receive CRS+HIPEC;
- •(2) Age ranging from 18 to 75 years old;
- •(3) Body mass index (BMI): 18–31 kg/m²;
- •(4) American Society of Anesthesiologists (ASA) physical status classification Grade I–III;
- •(5) Voluntarily participate after full informed consent and sign the written informed consent form.
排除标准
- •(1) Scarring, skin infection or sensory disturbance on the skin surrounding target acupoints (Zusanli, Shangjuxu, Hegu, Neiguan);
- •(2) Pre-existing peripheral nerve injury or prior spinal surgery history;
- •(3) Implanted electronic devices such as cardiac pacemakers;
- •(4) Preoperative intestinal obstruction or severe gastrointestinal motility disorders;
- •(5) Long-term preoperative use of analgesic medications;
- •(6) Confirmed psychiatric or neurological disorders;
- •(7) Requirement for intraoperative colostomy;
- •(8) Cognitive dysfunction precluding cooperation with treatment and outcome assessments.
研究者
相似试验
招募中
不适用
A clinical study to confirm the efficacy and safety of hard contact lenses for vision correction (SS-200)Corneal astigmatismjRCT203226029030
招募中
1 期
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.2025-523587-20-00Gruenenthal GmbH24
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
招募中
1 期
A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)2025-522125-36-00Region Midtjylland15
已完成
1 期
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Rosuvastatin2023-503570-20-00Pfizer Inc.12
